We are RUBYnanomed
A non-invasive monitoring of cancer progression
RUBYnanomed is a spin-off from the International Iberian Nanotechnology Laboratory (INL). RUBYnanomed has developed a precise cancer snapshot tool, the RUBYchip®, a microfluidic device for isolating all types of circulating tumour cells (CTCs) from unprocessed whole blood. In this way, RUBYnanomed offers a non-invasive and real-time snapshot of cancer progression to oncologists.

Meet the team

Enrique Sánchez
CBO

Lorena Diéguez
CEO

Sara Abalde
CTO

Paulina Piairo
COO

Liliana Pires
Senior Scientist
Awards

2021

2020

2020

2020

2020

2020

2019

2019
2018
2017
2017
2016